Andri Papakonstantinou

Publikationer
CV
Populärvetenskap och samverkan

Artiklar

Article: ADVANCED SCIENCE. 2024;11(41):e2404510
Molecular Profiling Defines Three Subtypes of Synovial Sarcoma
Chen Y; Su Y; Cao X; Siavelis I; Leo IR; Zeng J; Tsagkozis P; Hesla AC; Papakonstantinou A; Liu X; Huang W-K; Zhao B; Haglund C; Ehnman M; Johansson H; Lin Y; Lehtioe J; Zhang Y; Larsson O; Li X; de Flon FH
Article: JAMA ONCOLOGY. 2024;10(10):1331-1341
Neoadjuvant Immune Checkpoint Inhibitors Plus Chemotherapy in Early Breast Cancer
Villacampa G; Navarro V; Matikas A; Ribeiro JM; Schettini F; Tolosa P; Martinez-Saez O; Sanchez-Bayona R; Ferrero-Cafiero JM; Salvador F; Papakonstantinou A; Prat A; Oliveira M; Pascual T
Article: CLINICAL CANCER RESEARCH. 2024;30(12):2647-2658
Comprehensive Genomic Profiling Alters Clinical Diagnoses in a Significant Fraction of Tumors Suspicious of Sarcoma
Ofverholm I; Wallander K; Haglund C; Chellappa V; Wejde J; Gellerbring A; Wirta V; Renevey A; Caceres E; Tsagkozis P; Mayrhofer M; Papakonstantinou A; Linder-Stragliotto C; Branstrom R; Larsson O; Lindberg J; Lin Y; de Flon FH
Article: ACTA ONCOLOGICA. 2024;63:39851-293
Discontinuation of imatinib in patients with oligometastatic gastrointestinal stromal tumour who are in complete radiological remission: a prospective multicentre phase II study
Hompland I; Boye K; Wiedswang AM; Papakonstantinou A; Rosok B; Joensuu H; Bruland O
Article: PLOS ONE. 2024;19(8):e0308387
The observational EURACAN prospective clinical registry dedicated to epithelioid hemangioendothelioma: The protocol of an international and collaborative effort on an ultra-rare entity
Frezza AM; Leonard H; Aggerholm-Pedersen N; Badalamenti G; Baili P; Baldi GG; Bauer S; Bazzurri S; Benzonelli I; Bertuzzi A; Blay J-Y; Bianchi G; Bonfarnuzzo S; Bouvier C; Boye K; Broto JM; Brunello A; Campanacci D; Casali PG; Cicala C; Crotti E; D'Ambrosio L; Dei Tos AP; Dieckmann N; Dufresne A; Elston S; Ferraresi V; Gabellini S; Giani C; Giannusa V; Sanjines MG; Grassani T; Gronchi A; Lasalvia P; Lindskog S; Hindi N; Ingrosso M; Ivanescu A; Jones R; Lugowska I; Ketzer J; Mariuk-Jarema A; Mazzocca A; Monteleone L; Morosi C; Napolitano A; Nardozza F; Neri E; Nilsson M; Papakonstantinou A; Pasquali S; Sbaraglia M; Scolari F; Szkandera J; Valverde C; Vincenzi B; Vizzaccaro S; Zuccheri F; Stacchiotti S; Trama A
Article: BRITISH JOURNAL OF SURGERY. 2023;110(12):1857-1862
Long-term outcome after surgical resection of non-high-risk gastrointestinal stromal tumours without adjuvant therapy
Berndsen M; Renberg S; Holmebakk T; Hancke E; Puls F; Karlsson F; Stoldt S; Bjerkehagen B; de Flon FH; Muth A; Papakonstantinou A; Boye K; Lindskog S
Article: FRONTIERS IN ONCOLOGY. 2023;13:1095251
Long-term and real-life incidence of cancer therapy-related cardiovascular toxicity in patients with breast cancer: a Swedish cohort study
Hubbert L; Mallios P; Karlstrom P; Papakonstantinou A; Bergh J; Hedayati E
Article: INTERNATIONAL JOURNAL OF CANCER. 2022;151(6):906-913
The role of neoadjuvant imatinib in gastrointestinal stromal tumor patients: 20 years of experience from a tertial referral center
Renberg S; Zhang Y; Karlsson F; Branstrom R; Ahlen J; Jalmsell L; Linder-Stragliotto C; Haglund de Flon F; Papakonstantinou A
Article: CANCER MEDICINE. 2022;11(14):2729-2734
Diagnosing gastrointestinal stromal tumors: The utility of fine-needle aspiration cytology versus biopsy
Zhang Y; Renberg S; Papakonstantinou A; de Flon FH
Article: BIOMOLECULES. 2022;12(2):292
Evaluation of PD-L1 Expression in Undifferentiated Pleomorphic Sarcomas, Liposarcomas and Chondrosarcomas
Zhang Y; Chen Y; Papakonstantinou A; Tsagkozis P; Linder-Stragliotto C; Haglund F
Article: CANCERS. 2021;13(5):1175
CD11c-CD8 Spatial Cross Presentation: A Novel Approach to Link Immune Surveillance and Patient Survival in Soft Tissue Sarcoma
Su Y; Tsagkozis P; Papakonstantinou A; Tobin NP; Gultekin O; Malmerfelt A; Ingelshed K; Neo SY; Lundquist J; Chaabane W; Nisancioglu MH; Leiss LW; Ostman A; Bergh J; Sedimbi S; Lehti K; Lundqvist A; Stragliotto CL; Haglund F; Ehnman M
Article: EUROPEAN HEART JOURNAL - QUALITY OF CARE AND CLINICAL OUTCOMES. 2020;6(2):147-155
Outcome and presentation of heart failure in breast cancer patients: findings from a Swedish register-based study
Hedayati E; Papakonstantinou A; Gernaat SAM; Altena R; Brand JS; Alfredsson J; Bhoo-Pathy N; Herrmann J; Linde C; Dahlstrom U; Bergh J; Hubbert L
Article: CANCER. 2020;126(6):1175-1182
Efficacy and Safety of Tailored and Dose-Dense Adjuvant Chemotherapy and Trastuzumab for Resected HER2-Positive Breast Cancer: Results From the Phase 3 PANTHER Trial
Papakonstantinou A; Matikas A; Bengtsson NO; Malmstrom P; Hedayati E; Steger G; Untch M; Hubbert L; Johansson H; Hellstrom M; Gnant M; Loibl S; Greil R; Moebus V; Foukakis T; Bergh J
Article: ACTA ONCOLOGICA. 2020;59(1):75-81
Neutropenic complications in the PANTHER phase III study of adjuvant tailored dose-dense chemotherapy in early breast cancer
Papakonstantinou A; Hedayati E; Hellstrom M; Johansson H; Gnant M; Steger G; Greil R; Untch M; Moebus V; Loibl S; Foukakis T; Bergh J; Matikas A
Article: CARDIO-ONCOLOGY. 2020;6(1):16
Approaches to management of cardiovascular morbidity in adult cancer patients - cross-sectional survey among cardio-oncology experts
Hedayati E; Papakonstantinou A; Mansson-Broberg A; Bergh J; Hubbert L; Altena R
Article: BRITISH JOURNAL OF CANCER. 2019;120(4):435-443
Drug sensitivity testing on patient-derived sarcoma cells predicts patient response to treatment and identifies c-Sarc inhibitors as active drugs for translocation sarcomas
Brodin BA; Wennerberg K; Lidbrink E; Brosjo O; Potdar S; Wilson JN; Ma L; Moens LN; Hesla A; Porovic E; Bernhardsson E; Papakonstantinou A; Bauer H; Tsagkozis P; von Sivers K; Wejde J; Ostling P; Kallioniemi O; Stragliotto CL
Article: JOURNAL OF CLINICAL ONCOLOGY. 2016;34(14):1573-1579
Is Estradiol Monitoring Necessary in Women Receiving Ovarian Suppression for Breast Cancer?
Papakonstantinou A; Foukakis T; Rodriguez-Wallberg KA; Bergh J

Alla övriga publikationer

Review: NPJ BREAST CANCER. 2024;10(1):50
Use of ctDNA in early breast cancer: analytical validity and clinical potential
Panet F; Papakonstantinou A; Borrell M; Vivancos J; Vivancos A; Oliveira M
Review: ONCOLOGIST. 2024;29(1):1-7
Impact of Primary Breast Surgery on Overall Survival of Patients With De Novo Metastatic Breast Cancer: A Systematic Review and Meta-Analysis
Villacampa G; Papakonstantinou A; Fredriksson I; Matikas A
Review: JOURNAL OF INTERNAL MEDICINE. 2023;294(6):690-707
Sarcoma care in the era of precision medicine
Wallander K; Ofverholm I; Boye K; Tsagkozis P; Papakonstantinou A; Lin Y; de Flon FH
Review: EUROPEAN JOURNAL OF CANCER. 2023;190:112885
Landscape of neoadjuvant therapy in HER2-positive breast cancer: a systematic review and network meta-analysis
Villacampa G; Matikas A; Oliveira M; Prat A; Pascual T; Papakonstantinou A
Review: CANCERS. 2023;15(13):3290
New Insights in the Era of Clinical Biomarkers as Potential Predictors of Systemic Therapy-Induced Cardiotoxicity in Women with Breast Cancer: A Systematic Review
Alexandraki A; Papageorgiou E; Zacharia M; Keramida K; Papakonstantinou A; Cipolla CM; Tsekoura D; Naka K; Mazzocco K; Mauri D; Tsiknakis M; Manikis GC; Marias K; Marcou Y; Kakouri E; Konstantinou I; Daniel M; Galazi M; Kampouroglou E; Ribnikar D; Brown C; Karanasiou G; Antoniades A; Fotiadis D; Filippatos G; Constantinidou A
Review: CANCER TREATMENT REVIEWS. 2022;111:102470
The conundrum of breast cancer and microbiome- A comprehensive review of the current evidence
Papakonstantinou A; Nuciforo P; Borrell M; Zamora E; Pimentel I; Saura C; Oliveira M
Review: CANCERS. 2022;14(19):4665
Pharmacogenomics for Prediction of Cardiovascular Toxicity: Landscape of Emerging Data in Breast Cancer Therapies
Altena R; Bajalica-Lagercrantz S; Papakonstantinou A
Review: CARDIO-ONCOLOGY. 2022;8(1):16
A systematic review of miRNAs as biomarkers for chemotherapy-induced cardiotoxicity in breast cancer patients reveals potentially clinically informative panels as well as key challenges in miRNA research
Brown C; Mantzaris M; Nicolaou E; Karanasiou G; Papageorgiou E; Curigliano G; Cardinale D; Filippatos G; Memos N; Naka KK; Papakostantinou A; Vogazianos P; Ioulianou E; Shammas C; Constantinidou A; Tozzi F; Fotiadis DI; Antoniades A
Conference publication: JOURNAL OF CLINICAL ONCOLOGY. 2022;40(16):11535
Discontinuation of imatinib in patients with oligo-metastatic gastrointestinal stromal tumor who are in complete radiological remission: A prospective multicenter phase II study.
Hompland I; Boye K; Papakonstantinou A; Rosok B; Joensuu H; Bruland O
Review: CANCER TREATMENT REVIEWS. 2022;104:102362
Prognostic value of ctDNA detection in patients with early breast cancer undergoing neoadjuvant therapy: A systematic review and meta-analysis
Papakonstantinou A; Gonzalez NS; Pimentel I; Sunol A; Zamora E; Ortiz C; Espinosa-Bravo M; Peg V; Vivancos A; Saura C; Villacampa G; Oliveira M
Review: CANCERS. 2021;13(12):2927
Brain Metastases in HER2-Positive Breast Cancer: Current and Novel Treatment Strategies
Garcia-Alvarez A; Papakonstantinou A; Oliveira M
Review: CANCERS. 2021;13(6):1202
Current Status of Management and Outcome for Patients with Ewing Sarcoma
Hesla AC; Papakonstantinou A; Tsagkozis P
Thesis / dissertation: 2020
Studies of side effects related to adjuvant breast cancer regimens with focus on chemotherapy
Papakonstantinou, Andri
Letter: JOURNAL OF CLINICAL ONCOLOGY. 2017;35(1):121-122
Estradiol Level and Menopause Reply
Papakonstantinou A; Foukakis T; Rodriguez-Wallberg KA; Bergh J
Review: LAKARTIDNINGEN. 2016;113:DYIE
[Cardiotoxicity relatively common in cancer treatment].
Bühlmann Lerjen E; Hübbert L; Papakonstantinou A; Hedayati E; Linde C; Månsson Broberg A

Anställningar

Anknuten till Forskning, Onkologi-Patologi, Karolinska Institutet, 2023-2026

Examina och utbildning

Medicine Doktorsexamen, Institutionen för onkologi-patologi, Karolinska Institutet, 2020

Artiklar

Alla övriga publikationer

Anställningar

Examina och utbildning

Nyheter från KI

Kalenderhändelser från KI